D-Index & Metrics Best Publications
Medicine
Canada
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 123 Citations 75,723 687 World Ranking 1821 National Ranking 62

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Canada Leader Award

2010 - Fellow of the Royal Society of Canada Academy of Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Disease

His primary areas of study are Asthma, Immunology, Internal medicine, Inhalation and Anesthesia. His studies in Asthma integrate themes in fields like Placebo, Methacholine, Randomized controlled trial and Physical therapy. His Physical therapy research incorporates elements of MEDLINE, Intensive care medicine, Global health, Asthma Control Questionnaire and Risk factor.

His Immunology research focuses on Airway and how it relates to Bronchoalveolar lavage. Paul M. O'Byrne has researched Internal medicine in several fields, including Gastroenterology and Endocrinology. His study in Budesonide is interdisciplinary in nature, drawing from both Exacerbation and Bronchodilator.

His most cited work include:

  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (8591 citations)
  • Global strategy for asthma management and prevention: GINA executive summary. (2231 citations)
  • Development and validation of a questionnaire to measure asthma control (1714 citations)

What are the main themes of his work throughout his whole career to date?

Asthma, Immunology, Internal medicine, Inhalation and Anesthesia are his primary areas of study. His work in Asthma addresses issues such as Methacholine, which are connected to fields such as Provocation test. His Immunology course of study focuses on Airway and Bronchoalveolar lavage.

His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine. The study incorporates disciplines such as Bronchodilator and Crossover study in addition to Anesthesia. His Budesonide research includes elements of Exacerbation, Terbutaline and Physical therapy.

He most often published in these fields:

  • Asthma (53.10%)
  • Immunology (45.60%)
  • Internal medicine (24.24%)

What were the highlights of his more recent work (between 2013-2021)?

  • Asthma (53.10%)
  • Immunology (45.60%)
  • Internal medicine (24.24%)

In recent papers he was focusing on the following fields of study:

Paul M. O'Byrne focuses on Asthma, Immunology, Internal medicine, Allergen and Placebo. His Asthma research is multidisciplinary, incorporating elements of Crossover study, Anesthesia, Airway and Methacholine. Paul M. O'Byrne works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Exhaled nitric oxide, as a part of the same area of interest.

His study on Allergen also encompasses disciplines like

  • Inhalation that intertwine with fields like Intensive care medicine,
  • Receptor expression together with Interleukin. The Placebo study combines topics in areas such as Exacerbation, Tolerability, Adverse effect and Anti-asthmatic Agent. His Budesonide study combines topics from a wide range of disciplines, such as Post-hoc analysis and Maintenance therapy.

Between 2013 and 2021, his most popular works were:

  • Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses (520 citations)
  • A summary of the new GINA strategy: a roadmap to asthma control (464 citations)
  • Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial (264 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Asthma
  • Disease

His primary areas of study are Asthma, Immunology, Anesthesia, Internal medicine and Allergen. His Asthma research is multidisciplinary, incorporating perspectives in Placebo, Inhalation, Airway and MEDLINE. His research integrates issues of Global health, Physical therapy, Family medicine and Intensive care medicine in his study of MEDLINE.

Paul M. O'Byrne has included themes like Biomarker, Interquartile range, Adverse effect and Methacholine in his Anesthesia study. His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Bronchial hyperresponsiveness and other disciplines. Paul M. O'Byrne has researched Allergen in several fields, including Gene expression, DNA methylation, Eosinophilia, Myeloid and Bone marrow.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

JC Grotta;M Kothari;Kma Welch.
The New England Journal of Medicine (1995)

13680 Citations

Global strategy for asthma management and prevention: GINA executive summary.

Bateman Ed;Hurd Ss;Barnes Pj;Bousquet J.
European Respiratory Journal (2008)

3980 Citations

Development and validation of a questionnaire to measure asthma control

E. F. Juniper;P. M. O'Byrne;G. H. Guyatt;P. J. Ferrie.
European Respiratory Journal (1999)

2580 Citations

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

Romain A. Pauwels;Claes-Göran Löfdahl;Dirkje S. Postma;Anne E. Tattersfield.
The New England Journal of Medicine (1997)

2077 Citations

Airway Responsiveness. Standardized Challenge Testing With Pharmacological, Physical and Sensitizing Stimuli in Adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

P. J. Sterk;Leonardo Fabbri;P. H. Quanjer;D. W. Cockcroft.
The European respiratory journal. Supplement (1993)

1529 Citations

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

Parameswaran Nair;Marcia M M Pizzichini;Melanie Kjarsgaard;Mark D Inman.
The New England Journal of Medicine (2009)

1509 Citations

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)

1426 Citations

Treatment of Asthma with Drugs Modifying the Leukotriene Pathway

Jeffrey M. Drazen;Elliot Israel;Paul M. O'Byrne.
The New England Journal of Medicine (1999)

1140 Citations

Managing Cough as a Defense Mechanism and as a Symptom: A Consensus Panel Report of the American College of Chest Physicians

Richard S. Irwin;Louis-Philipe Boulet;Michelle M. Cloutier;Richard Fuller.
Chest (1998)

1012 Citations

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

Romain A Pauwels;Søren Pedersen;William W Busse;Wan C Tan.
The Lancet (2003)

950 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul M. O'Byrne

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 262

Peter J. Barnes

Peter J. Barnes

Imperial College London

Publications: 174

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 171

Jean Bousquet

Jean Bousquet

Grenoble Alpes University

Publications: 158

David Price

David Price

University of Aberdeen

Publications: 151

Christopher E. Brightling

Christopher E. Brightling

University of Leicester

Publications: 147

Kian Fan Chung

Kian Fan Chung

Imperial College London

Publications: 146

William W. Busse

William W. Busse

University of Wisconsin–Madison

Publications: 132

Stephen T. Holgate

Stephen T. Holgate

University of Southampton

Publications: 127

Stanley J. Szefler

Stanley J. Szefler

University of Colorado Denver

Publications: 123

Louis-Philippe Boulet

Louis-Philippe Boulet

Université Laval

Publications: 114

Peter J. Sterk

Peter J. Sterk

University of Amsterdam

Publications: 111

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 111

Parameswaran Nair

Parameswaran Nair

McMaster University

Publications: 110

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 110

Lee H. Schwamm

Lee H. Schwamm

Harvard University

Publications: 109

Trending Scientists

Jean-Luc Guermond

Jean-Luc Guermond

Texas A&M University

Michael E. Webber

Michael E. Webber

The University of Texas at Austin

Cheng-Gang Niu

Cheng-Gang Niu

Hunan University

Hiroshi Morita

Hiroshi Morita

Hoshi University

Murray Goodman

Murray Goodman

York University

Michael E. Jung

Michael E. Jung

University of California, Los Angeles

Hongwei Song

Hongwei Song

Jilin University

Mohan Edirisinghe

Mohan Edirisinghe

University College London

Wilfried Ellmeier

Wilfried Ellmeier

Medical University of Vienna

Daniel Eduardo Buschiazzo

Daniel Eduardo Buschiazzo

National Scientific and Technical Research Council

Haikun Wang

Haikun Wang

Nanjing University

Dawn Bowers

Dawn Bowers

University of Florida

Robin A. Hanks

Robin A. Hanks

Wayne State University

Stephen J. Suomi

Stephen J. Suomi

National Institutes of Health

D. C. Rao

D. C. Rao

Washington University in St. Louis

Jens Hjorth

Jens Hjorth

University of Copenhagen

Something went wrong. Please try again later.